| __timestamp | MorphoSys AG | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 55962693 | 15411924 |
| Thursday, January 1, 2015 | 78655788 | 22593274 |
| Friday, January 1, 2016 | 95723069 | 33173050 |
| Sunday, January 1, 2017 | 116808575 | 62224159 |
| Monday, January 1, 2018 | 106397017 | 95607434 |
| Tuesday, January 1, 2019 | 108431600 | 221269028 |
| Wednesday, January 1, 2020 | 141426832 | 400745069 |
| Friday, January 1, 2021 | 225200000 | 580520000 |
| Saturday, January 1, 2022 | 297812160 | 663366000 |
| Sunday, January 1, 2023 | 283614139 | 755113687 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, argenx SE and MorphoSys AG have been at the forefront of this race. Since 2014, argenx SE has increased its R&D expenses by an astounding 4,800%, reaching a peak in 2023. In contrast, MorphoSys AG has seen a more modest growth of approximately 400% over the same period. This stark difference highlights argenx SE's aggressive investment strategy, which has consistently outpaced its German counterpart. By 2023, argenx SE's R&D spending was more than double that of MorphoSys AG, underscoring its ambition to lead in the biotech sector. As these companies continue to innovate, their R&D investments will be crucial in shaping the future of medical breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Alnylam Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
argenx SE or Opthea Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
Research and Development Investment: argenx SE vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
R&D Spending Showdown: argenx SE vs Veracyte, Inc.
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
R&D Spending Showdown: BeiGene, Ltd. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and MorphoSys AG
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG